Author Archives: Jan Paschal

Apnimed (APMD Proposed), a Phase 3  biotech developing what could become the first FDA-approved pill to treat obstructive sleep apnea, disclosed its IPO’s terms and launched the $150 million deal early today – Monday, July 27, 2026. Apnimed is offering 10 million shares at a price range of $14.00 to $16.00 to raise $150 million, […]

Scribe Therapeutics  (SCTX) upsized its IPO at pricing to 8.58 million shares – up from 7.15 million in the prospectus – and priced the deal at $15.00 – the top of its range – to raise $128.7 million on Thursday night, July 23, 2026. Scribe’s stock jumped nearly 67 percent – opening at $25.00 – […]

Scribe Therapeutics (SCTX Proposed), an Eli Lilly-backed Phase 1 biotech  developing drugs to lower cholesterol and triglyceride levels, launched its $100.1 million IPO early today – with plans to price it later this week. The company, based in Alameda, California, is offering 7.15 million shares at a price range of $13.00 to $15.00 to raise […]

Reformation Inc. (REF Proposed), a retailer of women’s sustainable clothing, launched its $225 million IPO early today – after the sun rose over Wall Street. The Vernon, California-based company’s IPO will consist of 14.06 million shares at a price range of $15.00 to $17.00 to raise about $225 million – if priced at the $16.00 […]

Jersey Mike’s Subs Inc. (JMKE Proposed) launched its $1 billion IPO early today – 43.48 million shares at a price range of $21.00 to $25.00 – in its S-1/A filing dated July 20, 2026. The IPO would raise $999.99 million – about $1 billion – if priced at the $23.00 mid-point. Jersey Mike’s Subs Inc., […]

Csquare, Inc. (CSQR) priced its IPO at $21.00 – $2.00 below the bottom of its range – and sold 50 million shares – the number in the prospectus – to raise $1.05 billion on Wednesday night, July 15, 2026. Bloomberg reported that the IPO had been priced at $21.00 early Wednesday evening, quoting “people familiar […]

No surprises: Standard Nuclear (STDN) priced its sharply downsized deal at $15.00 – and sold 10 million shares – the terms in the prospectus – to raise $150 mlllion on Wednesday night, July 15, 2026. Earlier in the day, Standard Nuclear had slashed the IPO’s size in an S-1/A filing. The original terms were 18.25 million […]

Standard Nuclear (STDN Proposed) slashed the size of its IPO to $150 million – down from $355.88 million originally – in an S-1/A filing early today (Wednesday, July 15, 2026) – in the countdown to pricing the deal tonight. The IPO’s new terms call for Standard Nuclear to offer 10 million shares at an IPO price […]

Two of this year’s top IPO sectors – AI data centers and nuclear energy – share the mid-July marquee. Csquare (CSQR Proposed), a data center operator in  the U.S., Canada and the U.K., and Standard Nuclear (STDN Proposed), an early-stage producer of nuclear fuel, plan to go public this week and raise a total of […]

SK Hynix (SKHYV) (SKHY) made Wall Street history by pricing its NASDAQ Uplisting deal at $149.00 per American Depositary Share (ADS) on Thursday, July 9, 2026, to become the largest ADS offering ever done. The South Korean company priced 177.9 million ADS at $149.00 each to raise $26.51 billion. (Editor’s Note: The column, posted Thursday […]